8-K ·Filed Sep 15, 2026

ABEO

ABEONA THERAPEUTICS INC.
NEUTRAL
Impact 2/10
Horizonimmediate Processed17d 1h ago SEC0001493152-26-042702
Actionable Insight • Neutral

Monitor the conference presentation for any pipeline updates or strategic commentary that could move the stock. Without access to the presentation content, the filing itself provides no actionable trading signal.

DirectionNeutral
Confidencelow
Horizonimmediate
Latest settled — T+5d
ABEO ▲ +1.83% at T+5d
NEUTRAL call ✓ call won +1.83% · α vs SPY +1.01% · entry $5.47 → $5.57
Next anchor: T+20d in 11d
Latest observation: T+8 -4.25% FF3 residual α
Entry anchored
Sep 15, 12:00 PM ET
via 1-min bar
T+1d
-1.55%
call -1.55% · α -1.88%
$5.39
settled 16d ago
T+5d
+1.83%
call +1.83% · α +1.01%
$5.57
settled 10d ago
T+20d
—
call — · α —
—
in 11d
T+60d
—
call — · α —
—
in 2mo

Price Chart

Loading chart...

Executive Summary

Abeona Therapeutics filed an 8-K furnishing an updated investor presentation for the H.C. Wainwright 28th Annual Global Investment Conference on September 15, 2026. The filing is a routine Regulation FD disclosure of a conference presentation with no new material financial data or guidance provided. The presentation content was not available for review, limiting the analysis to the filing's metadata.

Key Facts

  • Filed 8-K on September 15, 2026 to furnish an updated investor presentation.
  • Presentation to be used at the H.C. Wainwright 28th Annual Global Investment Conference.
  • No financial results, guidance, or material corporate events disclosed in the filing text.
  • Presentation content (Exhibit 99.1) was not available for analysis.

Financial Impact

No financial data disclosed in the filing.

Risk Factors

  • Lack of access to the investor presentation limits visibility into any forward-looking statements or pipeline updates.
  • Routine conference presentations rarely contain material new information, limiting near-term catalysts.

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
92% bullish (12 analysts)

Investment Themes

Biotech & Drug Discovery

Documents Analyzed

This report is based on 5 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (ABEO) — Batch item 10001493152-26-042702
Document: 0001493152-26-042702-index-headers.html0001493152-26-042702
Document: 0001493152-26-042702-index.html0001493152-26-042702
Document: 0001493152-26-042702.txt0001493152-26-042702
8-K Filing (ABEO) — Batch item 50001493152-26-042702
19 reports for ABEO
Performance horizon
33% Hit rate 1 of 3 directional calls best @ T+1▲ +3.70%Aug 14, 2026
Filters
Rows
Reports for ABEO — sortable, filterable
TypeNow
Sep 15, 2026
17d ago
8-K
NEUTRAL ★ 2/10
$5.47 $5.57▲ +1.83%▲ +1.01%$5.03 (−8.14%)
Aug 14, 2026
6w ago
Institutional Cluster
BULLISH ★ 5/10
$5.94 $6.06▲ +2.02%▲ +3.21%$5.03 (−15.40%)
Aug 13, 2026
7w ago
8-K
NEUTRAL ★ 5/10
$6.35 $5.96▼ −6.07%▼ −4.10%$5.03 (−20.80%)
Aug 13, 2026
7w ago
Press Release
MIXED ★ 6/10
$6.35 $5.96▼ −6.07%▼ −4.10%$5.03 (−20.80%)
Jul 9, 2026
12w ago
Insider Cluster
NEUTRAL ★ 2/10
$6.98 $7.02▲ +0.57%▲ +1.13%$5.03 (−28.01%)
Jun 15, 2026
15w ago
Insider Cluster
NEUTRAL ★ 4/10
$5.65 $5.72▲ +1.24%▲ +3.47%$5.03 (−11.06%)
Jun 15, 2026
15w ago
Insider Cluster
BEARISH ★ 5/10
$5.65 $5.72▼ −1.24%▼ −3.47%$5.03 (+11.06%)
Jun 12, 2026
16w ago
8-K
NEUTRAL ★ 2/10
$5.53 $5.77▲ +4.34%▲ +3.67%$5.03 (−9.13%)
Jun 10, 2026
16w ago
8-K
NEUTRAL ★ 2/10
$5.53 $5.65▲ +2.17%▲ +1.74%$5.03 (−9.13%)
Jun 10, 2026
16w ago
Insider Cluster
BEARISH ★ 5/10
$5.36 $5.65▼ −5.41%▼ −1.98%$5.03 (+6.25%)
Showing 10 of 19

US Market Status

Market Open — Closes in 2h 19m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access